The U.S. Food and Drug Administration sent warning letters to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The FDA demanded that Bayer, Eli Lilly (LLY), Cephalon (CEPH) and Amylin Pharmaceuticals (AMLN) stop using ads the agency says exaggerate the efficacy of a drug or downplay its risks.
FDA Warns Four Drug Companies about Faulty Ads
Posted 7:35PM 01/14/10 Posted under: Company News, Health Care
The U.S. Food and Drug Administration sent warning letters to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The FDA demanded that Bayer, Eli Lilly (LLY), Cephalon (CEPH) and Amylin Pharmaceuticals (AMLN) stop using ads the agency says exaggerate the efficacy of a drug or downplay its risks.
AFP / Getty Images
- FACEBOOK IPO: What the %$#! Happened? - CNNMoney
- VERDICT IS IN: Jury: Google Didn't Violate Oracle's Patents - FOXBusiness
- WINNERS AND LOSERS: Banking in the Digital Age - InvestorPlace
- FACEBOOK AND LEHMAN BROS.: Two Very Different Ways to Run a Company - The Motley Fool
- Strong May Car Sales Seen Revving Up US GDP Growth - IBTimes
- Oil Drops Below $90 for 1st Time Since Nov. 1 - CBS MoneyWatch
- MASSIVE LAYOFFS: H-P Escapes Dell’s Executioner… But Its Workforce Doesn’t - 24/7 Wall St.
